Quantum Biopharma (QNTM) Expected to Announce Earnings on Monday

Quantum Biopharma (NASDAQ:QNTM) is anticipated to announce its results before the market opens on Monday, November 10th. Analysts expect the company to announce earnings of ($0.20) per share for the quarter.

Quantum Biopharma (NASDAQ:QNTM) last announced its earnings results on Wednesday, August 6th. The company reported ($3.23) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.17) by ($3.06). On average, analysts expect Quantum Biopharma to post $-3 EPS for the current fiscal year and $-2 EPS for the next fiscal year.

Quantum Biopharma Trading Down 11.7%

Shares of QNTM stock opened at $11.07 on Monday. Quantum Biopharma has a 1 year low of $2.70 and a 1 year high of $38.25. The firm’s 50 day moving average is $15.82 and its 200-day moving average is $16.69. The firm has a market capitalization of $42.29 million, a price-to-earnings ratio of -0.79 and a beta of 0.54.

Analyst Ratings Changes

A number of equities analysts have recently issued reports on QNTM shares. Weiss Ratings reiterated a “sell (e+)” rating on shares of Quantum Biopharma in a research report on Wednesday, October 8th. Wall Street Zen lowered shares of Quantum Biopharma from a “hold” rating to a “sell” rating in a report on Saturday. One equities research analyst has rated the stock with a Sell rating, According to MarketBeat, the stock has an average rating of “Sell”.

About Quantum Biopharma

Quantum Biopharma Ltd. is a biotechnology pharmaceutical research and development company, which focuses on the cultivation, process, and sale of medical cannabis. It operates through the Biotechnology and Strategic Investments segments. The Biotechnology segment is involved in the research and development of the company’s three drug candidates consisting of FSD-PEA, Lucid-PSYCH, and Lucid-MS.